Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis

Barbara Joyce-Shaikh, Michael E. Bigler, Cheng Chi Chao, Erin E. Murphy, Wendy M. Blumenschein, Iannis Adamopoulos, Paul G. Heyworth, Svetlana Antonenko, Edward P. Bowman, Terrill K. McClanahan, Joseph H. Phillips, Daniel J. Cua

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

DNAX adaptor protein 12 (DAP12) is a trans-membrane adaptor molecule that transduces activating signals in NK and myeloid cells. Absence of functional Dap12 results in osteoclast defects and bone abnormalities. Because DAP12 has no extracelluar binding domains, it must pair with cell surface receptors for signal transduction. There are at least 15 known DAP12-associating cell surface receptors with distinct temporal and cell type-specific expression patterns. Our aim was to determine which receptors may be important in DAP12-associated bone pathologies. Here, we identify myeloid DAP12-associating lectin (MDL)-1 receptor (also known as CLEC5A) as a key regulator of synovial injury and bone erosion during autoimmune joint inflammation. Activation of MDL-1 leads to enhanced recruitment of inflammatory macrophages and neutrophils to the joint and promotes bone erosion. Functional blockade of MDL-1 receptor via Mdl1 deletion or treatment with MDL-1-Ig fusion protein reduces the clinical signs of autoimmune joint inflammation. These findings suggest that MDL-1 receptor may be a therapeutic target for treatment of immune-mediated skeletal disorders.

Original languageEnglish (US)
Pages (from-to)579-589
Number of pages11
JournalJournal of Experimental Medicine
Volume207
Issue number3
DOIs
StatePublished - Mar 15 2010
Externally publishedYes

Fingerprint

Osteitis
Lectins
Arthritis
Mitogen Receptors
Bone and Bones
Proteins
Joints
Cell Surface Receptors
Inflammation
Osteoclasts
Myeloid Cells
Natural Killer Cells
Signal Transduction
Neutrophils
Macrophages
Pathology
Membranes
Wounds and Injuries

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. / Joyce-Shaikh, Barbara; Bigler, Michael E.; Chao, Cheng Chi; Murphy, Erin E.; Blumenschein, Wendy M.; Adamopoulos, Iannis; Heyworth, Paul G.; Antonenko, Svetlana; Bowman, Edward P.; McClanahan, Terrill K.; Phillips, Joseph H.; Cua, Daniel J.

In: Journal of Experimental Medicine, Vol. 207, No. 3, 15.03.2010, p. 579-589.

Research output: Contribution to journalArticle

Joyce-Shaikh, B, Bigler, ME, Chao, CC, Murphy, EE, Blumenschein, WM, Adamopoulos, I, Heyworth, PG, Antonenko, S, Bowman, EP, McClanahan, TK, Phillips, JH & Cua, DJ 2010, 'Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis', Journal of Experimental Medicine, vol. 207, no. 3, pp. 579-589. https://doi.org/10.1084/jem.20090516
Joyce-Shaikh, Barbara ; Bigler, Michael E. ; Chao, Cheng Chi ; Murphy, Erin E. ; Blumenschein, Wendy M. ; Adamopoulos, Iannis ; Heyworth, Paul G. ; Antonenko, Svetlana ; Bowman, Edward P. ; McClanahan, Terrill K. ; Phillips, Joseph H. ; Cua, Daniel J. / Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. In: Journal of Experimental Medicine. 2010 ; Vol. 207, No. 3. pp. 579-589.
@article{5d86833eb4b342ad96813e86cba5aaaf,
title = "Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis",
abstract = "DNAX adaptor protein 12 (DAP12) is a trans-membrane adaptor molecule that transduces activating signals in NK and myeloid cells. Absence of functional Dap12 results in osteoclast defects and bone abnormalities. Because DAP12 has no extracelluar binding domains, it must pair with cell surface receptors for signal transduction. There are at least 15 known DAP12-associating cell surface receptors with distinct temporal and cell type-specific expression patterns. Our aim was to determine which receptors may be important in DAP12-associated bone pathologies. Here, we identify myeloid DAP12-associating lectin (MDL)-1 receptor (also known as CLEC5A) as a key regulator of synovial injury and bone erosion during autoimmune joint inflammation. Activation of MDL-1 leads to enhanced recruitment of inflammatory macrophages and neutrophils to the joint and promotes bone erosion. Functional blockade of MDL-1 receptor via Mdl1 deletion or treatment with MDL-1-Ig fusion protein reduces the clinical signs of autoimmune joint inflammation. These findings suggest that MDL-1 receptor may be a therapeutic target for treatment of immune-mediated skeletal disorders.",
author = "Barbara Joyce-Shaikh and Bigler, {Michael E.} and Chao, {Cheng Chi} and Murphy, {Erin E.} and Blumenschein, {Wendy M.} and Iannis Adamopoulos and Heyworth, {Paul G.} and Svetlana Antonenko and Bowman, {Edward P.} and McClanahan, {Terrill K.} and Phillips, {Joseph H.} and Cua, {Daniel J.}",
year = "2010",
month = "3",
day = "15",
doi = "10.1084/jem.20090516",
language = "English (US)",
volume = "207",
pages = "579--589",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis

AU - Joyce-Shaikh, Barbara

AU - Bigler, Michael E.

AU - Chao, Cheng Chi

AU - Murphy, Erin E.

AU - Blumenschein, Wendy M.

AU - Adamopoulos, Iannis

AU - Heyworth, Paul G.

AU - Antonenko, Svetlana

AU - Bowman, Edward P.

AU - McClanahan, Terrill K.

AU - Phillips, Joseph H.

AU - Cua, Daniel J.

PY - 2010/3/15

Y1 - 2010/3/15

N2 - DNAX adaptor protein 12 (DAP12) is a trans-membrane adaptor molecule that transduces activating signals in NK and myeloid cells. Absence of functional Dap12 results in osteoclast defects and bone abnormalities. Because DAP12 has no extracelluar binding domains, it must pair with cell surface receptors for signal transduction. There are at least 15 known DAP12-associating cell surface receptors with distinct temporal and cell type-specific expression patterns. Our aim was to determine which receptors may be important in DAP12-associated bone pathologies. Here, we identify myeloid DAP12-associating lectin (MDL)-1 receptor (also known as CLEC5A) as a key regulator of synovial injury and bone erosion during autoimmune joint inflammation. Activation of MDL-1 leads to enhanced recruitment of inflammatory macrophages and neutrophils to the joint and promotes bone erosion. Functional blockade of MDL-1 receptor via Mdl1 deletion or treatment with MDL-1-Ig fusion protein reduces the clinical signs of autoimmune joint inflammation. These findings suggest that MDL-1 receptor may be a therapeutic target for treatment of immune-mediated skeletal disorders.

AB - DNAX adaptor protein 12 (DAP12) is a trans-membrane adaptor molecule that transduces activating signals in NK and myeloid cells. Absence of functional Dap12 results in osteoclast defects and bone abnormalities. Because DAP12 has no extracelluar binding domains, it must pair with cell surface receptors for signal transduction. There are at least 15 known DAP12-associating cell surface receptors with distinct temporal and cell type-specific expression patterns. Our aim was to determine which receptors may be important in DAP12-associated bone pathologies. Here, we identify myeloid DAP12-associating lectin (MDL)-1 receptor (also known as CLEC5A) as a key regulator of synovial injury and bone erosion during autoimmune joint inflammation. Activation of MDL-1 leads to enhanced recruitment of inflammatory macrophages and neutrophils to the joint and promotes bone erosion. Functional blockade of MDL-1 receptor via Mdl1 deletion or treatment with MDL-1-Ig fusion protein reduces the clinical signs of autoimmune joint inflammation. These findings suggest that MDL-1 receptor may be a therapeutic target for treatment of immune-mediated skeletal disorders.

UR - http://www.scopus.com/inward/record.url?scp=77949534181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949534181&partnerID=8YFLogxK

U2 - 10.1084/jem.20090516

DO - 10.1084/jem.20090516

M3 - Article

C2 - 20212065

AN - SCOPUS:77949534181

VL - 207

SP - 579

EP - 589

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -